Brii Biosciences Limited (BRIBF)
OTCMKTS
· Delayed Price · Currency is USD
0.2600
-0.0072 (-2.69%)
At close: May 5, 2025
Brii Biosciences Market Cap
Brii Biosciences has a market cap or net worth of $160.94 million as of May 20, 2025. Its market cap has increased by 76.38% in one year.
Market Cap
160.94M
Enterprise Value
-157.89M
Revenue
7.53M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.26
Market Cap Chart
Since July 13, 2021, Brii Biosciences's market cap has decreased from 2.09B to 160.94M, a decrease of -92.29%. That is a compound annual growth rate of -48.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2025 | 160.94M | 74.43% |
| Dec 31, 2024 | 92.26M | -56.66% |
| Dec 29, 2023 | 212.88M | -69.02% |
| Dec 30, 2022 | 687.16M | -77.39% |
| Dec 31, 2021 | 3.04B | 45.61% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo Inc. | 1.63B |
| Veradigm | 747.23M |
| Nika Pharmaceuticals | 672.83M |
| Tian'an Technology Group | 591.73M |
| Elite Pharmaceuticals | 551.66M |
| Glass House Brands | 483.63M |
| CytoDyn | 481.37M |
| Northwest Biotherapeutics | 420.38M |